Ambrosia Biosciences
Pre-clinicalOur scientific team brings deep expertise across every stage of structure-based drug discovery, with contributions to 30 IND filings, 25 new molecular entities, and 7 FDA approvals.
Founded
2018
Focus
Small Molecules
About
Our scientific team brings deep expertise across every stage of structure-based drug discovery, with contributions to 30 IND filings, 25 new molecular entities, and 7 FDA approvals.
Funding History
2Total raised: $17M
Series A$15MUndisclosedJun 15, 2023
Seed$2MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile